Noble International is working with Pharma and Specialty Pharmacy to fix the problem. The report, “The Current Paradigm for Biologic Initiation: A Mixed-Methods Exploration of Practices, Unmet Needs, and Innovation Opportunities in Self-Injection Training,” chronicles a study meant to examine the current injection initiation experiences of patients. Here, significant gaps in training and support were […]
noble
Noble Leads with its User-Centered Design Strategy
By Tim McLeroy, Executive Director of Marketing and Patient Services, Noble International At Noble, the patient journey drives everything we do. Our patient-centered approach pushes us to fully understand and characterize patient needs, providing data and experiences that help us ease the burden and anxiety of self-administered treatments. While drug delivery devices are well designed […]
Change Can Be Challenging: Especially for Patients
Noble Can Help Alleviate Patient Anxieties Caused by Switching to Biosimilar Therapies Change can be difficult for patients, particularly when embarking on a new treatment plan. Patients who require treatments for a variety of chronic illnesses—ranging from diabetes and rheumatoid arthritis to multiple sclerosis, Crohn’s disease and cancer— are increasingly prescribed biosimilar therapies to self-inject […]
Noble’s AdhereIT® Provides Flexibility of Design, Empowers Patients and Encourages Adherence
A recent study1 commissioned by Noble International analyzed the biologic initiation process and current gaps pertaining to patient guidance and self-injection training practices. Anecdotal evidence showed that more than one-third of participating patients lacked the necessary confidence to self-inject during their first six months of treatment due to inadequate training practices. The study further maintained […]
Paradigm Shift: How Noble Can Help Patients Reduce Errors During Biologic Initiation
Unmet Training Needs For Patients Using Self-Injectable Drug Therapies Comes At A High Cost A recent report published in Expert Opinion On Drug Delivery uncovered a startling paradigm regarding unmet training needs for patients who begin self-injectable therapies for chronic disease management. The authors of the report, “The current paradigm for biologic initiation: a mixed-methods […]
Noble can help patients reduce errors when self-administering biosimilar therapies
In today’s evolving healthcare environment, it’s not surprising that biosimilars have become more widely prescribed by physicians as an affordable alternative to biologics, which have been estimated to account for 38-40% of all pharmaceutical spending and average more than $100,000 per patient per year.1 Following this trend, in 2021, the biosimilar global market size was […]
Noble expands its services for its clients into Human Factors
Human Factors + (HF+) is a natural extension of Noble’s deep understanding of the patient experience relative to self-administering drug therapies By Tim McLeroy, Executive Director of Marketing & Patient Services The global market for medical devices is approximately $436 billion, bolstered by an aging population, according to data from hfMEDIC, the University of Utah-led […]
Noble launches AdhereIT platform for self-injection training
Noble this week launched its connected device platform, AdhereIT, to provide people that use auto-injectors with real-time feedback regarding their injection. Users can attach the AdhereIT system to an auto-injector training device or a commercial product, Noble reported. The platform can detect when the auto-injector makes contact with a user’s skin and the time when an […]
Noble aims to put patients at ease with auto-injector training devices
In the early days of auto-injectors, people learned how to use their devices by practicing with the skin of an orange, according to Noble‘s research manager, Joe Reynolds. “The rationale was ‘Well, let’s teach patients how to penetrate a skin-like membrane into a soft tissue to replicate what the human body would be like,’” he […]
